Abstract
Non-coding RNAs (ncRNAs) have key roles in the etiology of many illnesses, including heart failure, myocardial infarction, stroke, and in physiological processes like angiogenesis. In transcriptional regulatory circuits that control heart growth, signaling, and stress response, as well as remodeling in cardiac disease, ncRNAs have become important players. Studies on ncRNAs and cardiovascular disease have made great progress recently. Here, we go through the functions of non-coding RNAs (ncRNAs) like circular RNAs (circRNAs), and microRNAs (miRNAs) as well as long non-coding RNAs (lncRNAs) in modulating cardiovascular disorders.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
References
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R et al (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135(10):e146–e603
Eapen ZJ, Tang WH, Felker GM, Hernandez AF, Mahaffey KW, Lincoff AM et al (2012) Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward. Circ Cardiovasc Qual Outcomes 5(4):594–600
Milonas C, Jernberg T, Lindbäck J, Agewall S, Wallentin L, Stenestrand U (2010) Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. Am J Cardiol 105(9):1229–1234
Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW et al (2021) Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation 143(8):e254–e743
Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF et al (2017) Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol 70(20):2476–2486
Frangogiannis NG (2014) The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol 63(3):185–195
Seropian IM, Toldo S, Van Tassell BW, Abbate A (2014) Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol 63(16):1593–1603
Avan A, Hachinski V (2021) Stroke and dementia, leading causes of neurological disability and death, potential for prevention. Alzheimers Dement 17(6):1072–1076
Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA et al (2013) Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health 1(5):e259–e281
Murphy SJ, Werring DJ (2020) Stroke: causes and clinical features. Medicine 48(9):561–566
Kobiyama K, Ley K (2018) Atherosclerosis. Circ Res 123(10):1118–1120
Perrotta P, Emini Veseli B, Van der Veken B, Roth L, Martinet W, De Meyer GRY (2019) Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis. Vascul Pharmacol 112:72–78
Basic J, Stojkovic S, Assadian A, Rauscher S, Duschek N, Kaun C et al (2019) The relevance of vascular endothelial growth factor, hypoxia inducible factor-1 alpha, and clusterin in carotid plaque instability. J Stroke Cerebrovasc Dis 28(6):1540–1545
Gomes CPC, Schroen B, Kuster GM, Robinson EL, Ford K, Squire IB et al (2020) Regulatory RNAs in heart failure. Circulation 141(4):313–328
Li X, Zhang L, Liang J (2016) Unraveling the expression profiles of long noncoding RNAs in Rat cardiac hypertrophy and functions of lncRNA BC088254 in cardiac hypertrophy induced by transverse aortic constriction. Cardiology 134(2):84–98
Ottaviani L, da Costa Martins PA (2017) Non-coding RNAs in cardiac hypertrophy. J Physiol 595(12):4037–4050
Liao C, Gui Y, Guo Y, Xu D (2016) The regulatory function of microRNA-1 in arrhythmias. Mol BioSyst 12(2):328–333
Qin T, Li J, Zhang KQ (2020) Structure, regulation, and function of linear and circular long non-coding RNAs. Front Genet 11:150
Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96–118
Grabowski K, Herlan L, Witten A, Qadri F, Eisenreich A, Lindner D et al (2022) Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension. Hypertens Res 45(2):292–307
Zurek M, Johansson E, Palmer M, Albery T, Johansson K, Rydén-Markinhutha K et al (2020) Neuregulin-1 induces cardiac hypertrophy and impairs cardiac performance in post-myocardial infarction rats. Circulation 142(13):1308–1311
Yang Y, Ahn JM, Kang DY, Ko E, Kim S, Kim TO et al (2022) Implication of different ECG left ventricular hypertrophy in patients undergoing transcatheter aortic valve replacement. J Am Heart Assoc 11(4):e023647
Shimizu I, Minamino T (2016) Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol 97:245–262
Thum T, Condorelli G (2015) Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ Res 116(4):751–762
Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43(6):904–914
Matera AG, Wang Z (2014) A day in the life of the spliceosome. Nat Rev Mol Cell Biol 15(2):108–121
Zhao G (2018) Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases. J Med Genet 55(11):713–720
Guo JU, Agarwal V, Guo H, Bartel DP (2014) Expanded identification and characterization of mammalian circular RNAs. Genome Biol 15(7):409
Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495(7441):384–388
Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M et al (2014) circRNA biogenesis competes with pre-mRNA splicing. Mol Cell 56(1):55–66
Altesha MA, Ni T, Khan A, Liu K, Zheng X (2019) Circular RNA in cardiovascular disease. J Cell Physiol 234(5):5588–5600
Zhou MY, Yang JM, Xiong XD (2018) The emerging landscape of circular RNA in cardiovascular diseases. J Mol Cell Cardiol 122:134–139
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin QF, Xing YH et al (2013) Circular intronic long noncoding RNAs. Mol Cell 51(6):792–806
Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O et al (2017) Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis. Mol Cell 66(1):22-37.e9
Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L et al (2017) Translation of CircRNAs. Mol Cell 66(1):9-21.e7
Yang Y, Fan X, Mao M, Song X, Wu P, Zhang Y et al (2017) Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res 27(5):626–641
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao F et al (2018) Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. J Natl Cancer Inst 110(3):304–315
Fan X, Weng X, Zhao Y, Chen W, Gan T, Xu D (2017) Circular RNAs in cardiovascular disease: an overview. Biomed Res Int 2017:5135781
Wang W, Wang Y, Piao H, Li B, Huang M, Zhu Z et al (2019) Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease. PeerJ 7:e6831
Choi I, Lee S, Hong Y-K (2012) The new era of the lymphatic system: no longer secondary to the blood vascular system. Cold Spring Harbor Perspect Med 2(4):89
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):2335–2342
Wagner N, Wagner K-D (2023) Pharmacological utility of ppar modulation for angiogenesis in cardiovascular disease. Int J Mol Sci 24(3):2345
Makki N, Brennan TM, Girotra S (2015) Acute coronary syndrome. J Intensive Care Med 30(4):186–200
Eelen G, Treps L, Li X, Carmeliet P (2020) Basic and therapeutic aspects of angiogenesis updated. Circ Res 127(2):310–329
Helkin A, Maier KG, Gahtan V (2015) Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. Biochem Biophys Res Commun 464(4):1022–1027
Xie H, Cui Z, Wang L, Xia Z, Hu Y, Xian L et al (2014) PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med 20(11):1270–1278
Xu X, Zong Y, Gao Y, Sun X, Zhao H, Luo W et al (2019) VEGF induce vasculogenic mimicry of choroidal melanoma through the PI3k signal pathway. Biomed Res Int 2019:3909102
Bennett MR, Sinha S, Owens GK (2016) Vascular smooth muscle cells in atherosclerosis. Circ Res 118(4):692–702
Bieniasz-Krzywiec P, Martín-Pérez R, Ehling M, García-Caballero M, Pinioti S, Pretto S et al (2019) Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer. Cell Metab 30(5):917–36.e10
Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R et al (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21(3):425–532
Hernández-Romero IA, Guerra-Calderas L, Salgado-Albarrán M, Maldonado-Huerta T, Soto-Reyes E (2019) The regulatory roles of non-coding RNAs in angiogenesis and neovascularization from an epigenetic perspective. Front Oncol 9:1091
Müller S, Raulefs S, Bruns P, Afonso-Grunz F, Plötner A, Thermann R et al (2015) Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Mol Cancer 14:1–18
Fasolo F, Di Gregoli K, Maegdefessel L, Johnson JL (2019) Non-coding RNAs in cardiovascular cell biology and atherosclerosis. Cardiovasc Res 115(12):1732–1756
Poller W, Dimmeler S, Heymans S, Zeller T, Haas J, Karakas M et al (2018) Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur Heart J 39(29):2704–2716
Calway T, Kim GH (2015) Harnessing the therapeutic potential of MicroRNAs for cardiovascular disease. J Cardiovasc Pharmacol Ther 20(2):131–143
Kobayashi K, Maeda K, Takefuji M, Kikuchi R, Morishita Y, Hirashima M et al (2017) Dynamics of angiogenesis in ischemic areas of the infarcted heart. Sci Rep 7(1):7156
Liu R, Liu C, Cui L, Zhou L, Li N, Wei X (2019) Expression and significance of MiR-126 and VEGF in proliferative diabetic retinopathy. Eur Rev Med Pharmacol Sci 23(15):9
Meng S, Cao J-T, Zhang B, Zhou Q, Shen C-X, Wang C-Q (2012) Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol 53(1):64–72
Fu R, Tong JS (2020) miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells. J Cell Mol Med 24(13):7600–7608
Song L, Li D, Gu Y, Wen Z-M, Jie J, Zhao D et al (2016) MicroRNA-126 targeting PIK3R2 inhibits NSCLC A549 cell proliferation, migration, and invasion by regulation of PTEN/PI3K/AKT pathway. Clin Lung Cancer 17(5):e65–e75
Zhang L, Ouyang P, He G, Wang X, Song D, Yang Y et al (2021) Exosomes from microRNA-126 overexpressing mesenchymal stem cells promote angiogenesis by targeting the PIK3R2-mediated PI3K/Akt signalling pathway. J Cell Mol Med 25(4):2148–2162
Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B et al (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2(100):81
Fish JE, Santoro MM, Morton SU, Yu S, Yeh R-F, Wythe JD et al (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15(2):272–284
Ye P, Liu J, He F, Xu W, Yao K (2014) Hypoxia-induced deregulation of miR-126 and its regulative effect on VEGF and MMP-9 expression. Int J Med Sci 11(1):17
Zhang Y, Xu Y, Zhou K, Kao G, Xiao J (2022) MicroRNA-126 and VEGF enhance the function of endothelial progenitor cells in acute myocardial infarction. Exp Ther Med 23(2):142
Burek M, König A, Lang M, Fiedler J, Oerter S, Roewer N et al (2019) Hypoxia-induced microRNA-212/132 alter blood-brain barrier integrity through inhibition of tight junction-associated proteins in human and mouse brain microvascular endothelial cells. Transl Stroke Res 10(6):672–683
Lei Z, Klasson TD, Brandt MM, van de Hoek G, Logister I, Cheng C et al (2020) Control of angiogenesis via a VHL/miR-212/132 axis. Cells 9(4):1017
Eskildsen TV, Jeppesen PL, Schneider M, Nossent AY, Sandberg MB, Hansen PB et al (2013) Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci 14(6):11190–11207
Lei Z, Fang J, Deddens JC, Metz CH, Van Eeuwijk EC, El Azzouzi H et al (2020) Loss of miR-132/212 has no long-term beneficial effect on cardiac function after permanent coronary occlusion in mice. Front Physiol 11:590
Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S et al (2012) The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 3(1):1–11
Ma S, Meng Z, Chen R, Guan K-L (2019) The Hippo pathway: biology and pathophysiology. Annu Rev Biochem 88:577–604
Ma C, Peng P, Zhou Y, Liu T, Wang L, Lu C (2020) MicroRNA-93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarctionω. Mol Med Rep 22(1):483–493
Piccolo S, Dupont S, Cordenonsi M (2014) The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev 94(4):1287–1312
Fang L, Du WW, Yang W, Rutnam ZJ, Peng C, Li H et al (2012) MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 11(23):4352–4365
Kim J, Kim YH, Kim J, Bae H, Lee D-H, Kim KH et al (2017) YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Investig 127(9):3441–3461
Sakabe M, Fan J, Odaka Y, Liu N, Hassan A, Duan X et al (2017) YAP/TAZ-CDC42 signaling regulates vascular tip cell migration. Proc Natl Acad Sci 114(41):10918–10923
Choi H-J, Zhang H, Park H, Choi K-S, Lee H-W, Agrawal V et al (2015) Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2. Nat Commun 6(1):1–14
Zhou Q, Li L, Zhao B, Guan K-L (2015) The hippo pathway in heart development, regeneration, and diseases. Circ Res 116(8):1431–1447
Singh A, Ramesh S, Cibi DM, Yun LS, Li J, Li L et al (2016) Hippo signaling mediators Yap and Taz are required in the epicardium for coronary vasculature development. Cell Rep 15(7):1384–1393
Heallen T, Morikawa Y, Leach J, Tao G, Willerson JT, Johnson RL et al (2013) Hippo signaling impedes adult heart regeneration. Development 140(23):4683–4690
Matsui Y, Nakano N, Shao D, Gao S, Luo W, Hong C et al (2008) Lats2 is a negative regulator of myocyte size in the heart. Circ Res 103(11):1309–1318
Shao D, Zhai P, Del Re DP, Sciarretta S, Yabuta N, Nojima H et al (2014) A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun 5(1):1–10
Semenza GL (2016) Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization. J Investig Med 64(2):361–363
Devlin C, Greco S, Martelli F, Ivan M (2011) miR-210: More than a silent player in hypoxia. IUBMB Life 63(2):94–100
Voellenkle C, Garcia-Manteiga J, Pedrotti S, Perfetti A, De Toma I, Da Silva D et al (2016) Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci Rep 6(1):1–13
Chan SY, Zhang Y-Y, Hemann C, Mahoney CE, Zweier JL, Loscalzo J (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 10(4):273–284
Zaccagnini G, Maimone B, Di Stefano V, Fasanaro P, Greco S, Perfetti A et al (2014) Hypoxia-induced miR-210 modulates tissue response to acute peripheral ischemia. Antioxid Redox Signal 21(8):1177–1188
Fasanaro P, D’Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G et al (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283(23):15878–15883
Kim HW, Haider HK, Jiang S, Ashraf M (2009) Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 284(48):33161–33168
Kim HW, Jiang S, Ashraf M, Haider KH (2012) Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function. J Mol Med 90(9):997–1010
Zaccagnini G, Maimone B, Fuschi P, Maselli D, Spinetti G, Gaetano C et al (2017) Overexpression of miR-210 and its significance in ischemic tissue damage. Sci Rep 7(1):1–10
Guan Y, Song X, Sun W, Wang Y, Liu B (2019) Effect of hypoxia-induced microRNA-210 expression on cardiovascular disease and the underlying mechanism. Oxidative medicine and cellular longevity
Greco S, Gaetano C, Martelli F (2014) HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid Redox Signal 21(8):1202–1219
Zaccagnini G, Maimone B, Fuschi P, Longo M, Da Silva D, Carrara M et al (2019) Hypoxia-induced miR-210 is necessary for vascular regeneration upon acute limb ischemia. Int J Mol Sci 21(1):8
Gorin C, Rochefort GY, Bascetin R, Ying H, Lesieur J, Sadoine J et al (2016) Priming dental pulp stem cells with fibroblast growth factor-2 increases angiogenesis of implanted tissue-engineered constructs through hepatocyte growth factor and vascular endothelial growth factor secretion. Stem Cells Transl Med 5(3):392–404
Kaga T, Kawano H, Sakaguchi M, Nakazawa T, Taniyama Y, Morishita R (2012) Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor. Vascul Pharmacol 57(1):3–9
Awada HK, Johnson NR, Wang Y (2014) Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects. Macromol Biosci 14(5):679–686
Maltaneri RE, Schiappacasse A, Chamorro ME, Nesse AB, Vittori DC (2020) Aquaporin-1 plays a key role in erythropoietin-induced endothelial cell migration. Biochim Biophys Acta (BBA) 1867(1):118569
Sanada F, Taniyama Y, Iekushi K, Azuma J, Okayama K, Kusunoki H et al (2009) Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells. Circ Res 105(7):667–675
Sanada F, Taniyama Y, Azuma J, Iekushi K, Dosaka N, Yokoi T et al (2009) Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II–Induced endothelial progenitor cell senescence. Hypertension 53(1):77–82
Fan ZG, Qu XL, Chu P, Gao YL, Gao XF, Chen SL et al (2018) MicroRNA-210 promotes angiogenesis in acute myocardial infarction. Mol Med Rep 17(4):5658–5665
Wang X, Liu Y, Hou H, Shao W, Huang D, Hao Z et al (2022) miRNA-29 aggravates myocardial infarction via inhibiting the PI3K/mTOR/HIF1α/VEGF pathway. Aging (Albany NY) 14(7):3129–3142
Gao S, Gao H, Dai L, Han Y, Lei Z, Wang X et al (2021) miR-126 regulates angiogenesis in myocardial ischemia by targeting HIF-1α. Exp Cell Res 409(2):112925
Ma W, Zhang X, Liu Y (2021) miR-124 promotes apoptosis and inhibits the proliferation of vessel endothelial cells through P38/MAPK and PI3K/AKT pathways, making it a potential mechanism of vessel endothelial injury in acute myocardial infarction. Exp Ther Med 22(6):1383
Gui Y, Chen J, Hu J, Liao C, Ouyang M, Deng L et al (2020) Soluble epoxide hydrolase inhibitors improve angiogenic function of endothelial progenitor cells via ERK/p38-mediated miR-126 upregulation in myocardial infarction mice after exercise. Exp Cell Res 397(2):112360
Pang J, Ye L, Chen Q, Wang J, Yang X, He W et al (2020) The effect of MicroRNA-101 on angiogenesis of human umbilical vein endothelial cells during hypoxia and in mice with myocardial infarction. Biomed Res Int 2020:5426971
Song W, Liang Q, Cai M, Tian Z (2020) HIF-1α-induced up-regulation of microRNA-126 contributes to the effectiveness of exercise training on myocardial angiogenesis in myocardial infarction rats. J Cell Mol Med 24(22):12970–12979
Li X, Wei C, Zhang Z, Jin Q, Xiao X (2020) MiR-134-5p regulates myocardial apoptosis and angiogenesis by directly targeting KDM2A after myocardial infarction. Int Heart J 61(4):815–821
Hong Y, He H, Jiang G, Zhang H, Tao W, Ding Y et al (2020) miR-155–5p inhibition rejuvenates aged mesenchymal stem cells and enhances cardioprotection following infarction. Aging Cell 19(4):13128
Zaccagnini G, Maimone B, Fuschi P, Longo M, Da Silva D, Carrara M et al (2019) Hypoxia-induced miR-210 is necessary for vascular regeneration upon acute limb ischemia. Int J Mol Sci 21(1):129
Wang X, Shang Y, Dai S, Wu W, Yi F, Cheng L (2020) MicroRNA-16-5p aggravates myocardial infarction injury by targeting the expression of insulin receptor substrates 1 and mediating myocardial apoptosis and angiogenesis. Curr Neurovasc Res 17(1):11–17
Li X, Xue X, Sun Y, Chen L, Zhao T, Yang W et al (2019) MicroRNA-326-5p enhances therapeutic potential of endothelial progenitor cells for myocardial infarction. Stem Cell Res Ther 10(1):323
Li S-N, Li P, Liu W-H, Shang J-J, Qiu S-L, Zhou M-X et al (2019) Danhong injection enhances angiogenesis after myocardial infarction by activating MiR-126/ERK/VEGF pathway. Biomed Pharmacother 120:109538
Yan M, Chen K, Sun R, Lin K, Qian X, Yuan M et al (2019) Glucose impairs angiogenesis and promotes ventricular remodelling following myocardial infarction via upregulation of microRNA-17. Exp Cell Res 381(2):191–200
Li CC, Qiu XT, Sun Q, Zhou JP, Yang HJ, Wu WZ et al (2019) Endogenous reduction of miR-185 accelerates cardiac function recovery in mice following myocardial infarction via targeting of cathepsin K. J Cell Mol Med 23(2):1164–1173
Dong J, Zhang Z, Huang H, Mo P, Cheng C, Liu J et al (2018) miR-10a rejuvenates aged human mesenchymal stem cells and improves heart function after myocardial infarction through KLF4. Stem Cell Res Ther 9(1):151
Yang LX, Wei CL, Guo ML, Zhang Y, Bai F, Ma SG (2017) Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142. Oncotarget 8(49):85549–85558
Arif M, Pandey R, Alam P, Jiang S, Sadayappan S, Paul A et al (2017) MicroRNA-210-mediated proliferation, survival, and angiogenesis promote cardiac repair post myocardial infarction in rodents. J Mol Med (Berl) 95(12):1369–1385
Li K, Lin T, Chen L, Wang N (2017) MicroRNA-93 elevation after myocardial infarction is cardiac protective. Med Hypotheses 106:23–25
Zhu ML, Yin YL, Ping S, Yu HY, Wan GR, Jian X et al (2017) Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b. Clin Exp Hypertens 39(7):672–679
Xiao L, He H, Ma L, Da M, Cheng S, Duan Y et al (2017) Effects of miR-29a and miR-101a expression on myocardial interstitial collagen generation after aerobic exercise in myocardial-infarcted rats. Arch Med Res 48(1):27–34
Garikipati VNS, Verma SK, Jolardarashi D, Cheng Z, Ibetti J, Cimini M et al (2017) Therapeutic inhibition of miR-375 attenuates post-myocardial infarction inflammatory response and left ventricular dysfunction via PDK-1-AKT signalling axis. Cardiovasc Res 113(8):938–949
Castellan RF, Vitiello M, Vidmar M, Johnstone S, Iacobazzi D, Mellis D et al (2020) miR-96 and miR-183 differentially regulate neonatal and adult postinfarct neovascularization. JCI Insight 5(14):e134888
Templin C, Volkmann J, Emmert MY, Mocharla P, Müller M, Kraenkel N et al (2017) Increased proangiogenic activity of mobilized CD34+ progenitor cells of patients with acute ST-segment-elevation myocardial infarction: role of differential MicroRNA-378 expression. Arterioscler Thromb Vasc Biol 37(2):341–349
Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D et al (2011) MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124(6):720–730
Lu C, Wang X, Ha T, Hu Y, Liu L, Zhang X et al (2015) Attenuation of cardiac dysfunction and remodeling of myocardial infarction by microRNA-130a are mediated by suppression of PTEN and activation of PI3K dependent signaling. J Mol Cell Cardiol 89(Pt A):87–97
Kang HJ, Kang WS, Hong MH, Choe N, Kook H, Jeong HC et al (2015) Involvement of miR-34c in high glucose-insulted mesenchymal stem cells leads to inefficient therapeutic effect on myocardial infarction. Cell Signal 27(11):2241–2251
Wen Z, Huang W, Feng Y, Cai W, Wang Y, Wang X et al (2014) MicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGF. PLoS ONE 9(9):104666
Meloni M, Marchetti M, Garner K, Littlejohns B, Sala-Newby G, Xenophontos N et al (2013) Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol Ther 21(7):1390–1402
van Mil A, Vrijsen KR, Goumans MJ, Metz CH, Doevendans PA, Sluijter JP (2013) MicroRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells. J Mol Med (Berl) 91(8):1001–1012
Chen JJ, Zhou SH (2011) Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J 18(6):675–681
Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA et al (2010) MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122(11 Suppl):S124–S131
Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324(5935):1710–1713
Huang F, Zhu X, Hu XQ, Fang ZF, Tang L, Lu XL et al (2013) Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med 31(2):484–492
Bellera N, Barba I, Rodriguez-Sinovas A, Ferret E, Asín MA, Gonzalez-Alujas MT et al (2014) Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling. J Am Heart Assoc 3(5):e000946
Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA et al (2008) The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15(2):261–271
Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D et al (2010) Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J Clin Invest 120(11):4141–4154
McIntosh BE, Hogenesch JB, Bradfield CA (2010) Mammalian Per-Arnt-Sim proteins in environmental adaptation. Annu Rev Physiol 72:625–645
Shao A, Lang Y, Wang M, Qin C, Kuang Y, Mei Y et al (2020) Bclaf1 is a direct target of HIF-1 and critically regulates the stability of HIF-1α under hypoxia. Oncogene 39(13):2807–2818
Weidemann A, Johnson RS (2008) Biology of HIF-1alpha. Cell Death Differ 15(4):621–627
Gaete D, Rodriguez D, Watts D, Sormendi S, Chavakis T, Wielockx B (2021) HIF-prolyl hydroxylase domain proteins (PHDs) in cancer—potential targets for anti-tumor therapy? Cancers 13(5):988
Strowitzki MJ, Cummins EP, Taylor CT (2019) Protein hydroxylation by hypoxia-inducible factor (HIF) hydroxylases: unique or ubiquitous? Cells 8(5):384
Taguchi A, Yanagisawa K, Tanaka M, Cao K, Matsuyama Y, Goto H et al (2008) Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 68(14):5540–5545
Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J et al (2009) Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104(7):879–886
Gogiraju R, Xu X, Bochenek ML, Steinbrecher JH, Lehnart SE, Wenzel P et al (2015) Endothelial p53 deletion improves angiogenesis and prevents cardiac fibrosis and heart failure induced by pressure overload in mice. J Am Heart Assoc 4(2):89
Li Y, Yan C, Fan J, Hou Z, Han Y (2021) MiR-221-3p targets Hif-1α to inhibit angiogenesis in heart failure. Lab Invest 101(1):104–115
Fan J, Li H, Nie X, Yin Z, Zhao Y, Zhang X et al (2018) MiR-665 aggravates heart failure via suppressing CD34-mediated coronary microvessel angiogenesis. Aging (Albany NY) 10(9):2459–2479
Zhao Y, Yan M, Chen C, Gong W, Yin Z, Li H et al (2018) MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart. Oncotarget 9(18):14382–14396
Wang S, Wu J, You J, Shi H, Xue X, Huang J et al (2018) HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis. J Mol Cell Cardiol 118:193–207
Joladarashi D, Garikipati VNS, Thandavarayan RA, Verma SK, Mackie AR, Khan M et al (2015) Enhanced cardiac regenerative ability of stem cells after ischemia-reperfusion injury: role of human CD34+ cells deficient in MicroRNA-377. J Am Coll Cardiol 66(20):2214–2226
Duan Q, Yang L, Gong W, Chaugai S, Wang F, Chen C et al (2015) MicroRNA-214 Is upregulated in heart failure patients and suppresses XBP1-mediated endothelial cells angiogenesis. J Cell Physiol 230(8):1964–1973
Wang R, Bai Z, Wen X, Du H, Zhou L, Tang Z et al (2019) MiR-152-3p regulates cell proliferation, invasion and extracellular matrix expression through by targeting FOXF1 in keloid fibroblasts. Life Sci 234:116779
Łuczkowska K, Rogińska D, Ulańczyk Z, Machaliński B (2020) Effect of bortezomib on global gene expression in PC12-derived nerve cells. Int J Mol Sci 21(3):751
Marcon BH, Rebelatto CK, Cofré AR, Dallagiovanna B, Correa A (2020) DDX6 helicase behavior and protein partners in human adipose tissue-derived stem cells during early adipogenesis and osteogenesis. Int J Mol Sci 21(7):2607
Nicklas S, Okawa S, Hillje A-L, González-Cano L, Del Sol A, Schwamborn JC (2015) The RNA helicase DDX6 regulates cell-fate specification in neural stem cells via miRNAs. Nucleic Acids Res 43(5):2638–2654
Chauderlier A, Gilles M, Spolcova A, Caillierez R, Chwastyniak M, Kress M et al (2018) Tau/DDX6 interaction increases microRNA activity. Biochim Biophys Acta (BBA) 1861(8):762–772
de Vries S, Naarmann-de Vries IS, Urlaub H, Lue H, Bernhagen J, Ostareck DH et al (2013) Identification of DEAD-box RNA helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxia. J Biol Chem 288(8):5815–5827
Karaman S, Leppänen V-M, Alitalo K (2018) Vascular endothelial growth factor signaling in development and disease. Development 145(14):151019
Saito K, Kondo E, Matsushita M (2011) MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6. Nucleic Acids Res 39(14):6086–6099
Zhao Z, Wu C, He X, Zhao E, Hu S, Han Y et al (2021) miR-152-3p aggravates vascular endothelial cell dysfunction by targeting DEAD-box helicase 6 (DDX6) under hypoxia. Bioengineered 12(1):4899–4910
Choi GH, Ko KH, Kim JO, Kim J, Oh SH, Han IB et al (2016) Association of miR-34a, miR-130a, miR-150 and miR-155 polymorphisms with the risk of ischemic stroke. Int J Mol Med 38(1):345–356
He QW, Li Q, Jin HJ, Zhi F, Suraj B, Zhu YY et al (2016) MiR-150 regulates poststroke cerebral angiogenesis via vascular endothelial growth factor in rats. CNS Neurosci Ther 22(6):507–517
Fang Z, He QW, Li Q, Chen XL, Baral S, Jin HJ et al (2016) MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats. FASEB J 30(6):2097–2107
Liu X, Xu Y, Han L, Yi Y (2018) Reassessing the potential of Myb-targeted anti-cancer therapy. J Cancer 9(7):1259
Yang H, Zhang H, Ge S, Ning T, Bai M, Li J et al (2018) Exosome-derived miR-130a activates angiogenesis in gastric cancer by targeting C-MYB in vascular endothelial cells. Mol Ther 26(10):2466–2475
Wang W, Li C, Li W, Kong L, Qian A, Hu N et al (2014) MiR-150 enhances the motility of EPCs in vitro and promotes EPCs homing and thrombus resolving in vivo. Thromb Res 133(4):590–598
Sun X, Zhang C, Cao Y, Liu E (2019) miR-150 suppresses tumor growth in melanoma through downregulation of MYB. Oncol Res 27(3):317
Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z et al (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39(1):133–144
Zhang S, Chen A, Chen X (2021) A feedback loop involving microRNA-150 and MYB regulates VEGF expression in brain microvascular endothelial cells after oxygen glucose deprivation. Front Physiol 12:178
Zhang S, Chen A, Chen X (2021) A feedback loop involving MicroRNA-150 and MYB regulates VEGF expression in brain microvascular endothelial cells after oxygen glucose deprivation. Front Physiol 12:619904
Zheng T, Shi Y, Zhang J, Peng J, Zhang X, Chen K et al (2019) MiR-130a exerts neuroprotective effects against ischemic stroke through PTEN/PI3K/AKT pathway. Biomed Pharmacother 117:109117
Wang Y, Wang MD, Xia YP, Gao Y, Zhu YY, Chen SC et al (2018) MicroRNA-130a regulates cerebral ischemia–induced blood–brain barrier permeability by targeting Homeobox A5. FASEB J 32(2):935–944
Dasari VR, Velpula KK, Kaur K, Fassett D, Klopfenstein JD, Dinh DH et al (2010) Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS ONE 5(7):e11813
Obexer P, Ausserlechner MJ (2014) X-linked inhibitor of apoptosis protein–a critical death resistance regulator and therapeutic target for personalized cancer therapy. Front Oncol 4:197
Siegel C, Li J, Liu F, Benashski SE, McCullough LD (2011) miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci 108(28):11662–11667
Xa Z, Huang L, Zhao Y, Tan W (2013) Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Acta Biochim Biophys Sin 45(12):995–1001
Jost PJ, Vucic D (2020) Regulation of cell death and immunity by XIAP. Cold Spring Harb Perspect Biol 12(8):a036426
Kairisalo M, Korhonen L, Sepp M, Pruunsild P, Kukkonen JP, Kivinen J et al (2009) NF-κB-dependent regulation of brain-derived neurotrophic factor in hippocampal neurons by X-linked inhibitor of apoptosis protein. Eur J Neurosci 30(6):958–966
Wang W, Wang Q, Yu W, Chen L, Li Z (2018) Efficacy of phosphocreatine pre-administration on XIAP and Smac in ischemic penumbra of rats with focal cerebral ischemia reperfusion injury. Acta Cir Bras 33:117–124
Deng W, Fan C, Zhao Y, Mao Y, Li J, Zhang Y et al (2020) MicroRNA-130a regulates neurological deficit and angiogenesis in rats with ischaemic stroke by targeting XIAP. J Cell Mol Med 24(18):10987–11000
Schutt RC, Burdick MD, Strieter RM, Mehrad B, Keeley EC (2012) Plasma CXCL12 levels as a predictor of future stroke. Stroke 43(12):3382–3386
Gu X-L, Liu L, Lu X-D, Liu Z-R (2016) Serum CXCL12 levels as a novel predictor of future stroke recurrence in patients with acute ischemic stroke. Mol Neurobiol 53(5):2807–2814
Mei J, Li MQ, Li DJ, Sun HX (2017) MicroRNA expression profiles and networks in CXCL12-stimulated human endometrial stromal cells. Mol Med Rep 15(1):249–255
Jiang D, Sun X, Wang S, Man H (2019) Upregulation of miR-874-3p decreases cerebral ischemia/reperfusion injury by directly targeting BMF and BCL2L13. Biomed Pharmacother 117:108941
Wang W, Li M, Wang Y, Li Q, Deng G, Wan J et al (2016) GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats. Mol Neurobiol 53(10):7028–7036
Xu Y, Zhang G, Kang Z, Xu Y, Jiang W, Zhang S (2016) Cornin increases angiogenesis and improves functional recovery after stroke via the Ang1/Tie2 axis and the Wnt/β-catenin pathway. Arch Pharmacal Res 39(1):133–142
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan J et al (2013) MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. J Clin Invest 123(2):36
Xie K, Cai Y, Yang P, Du F, Wu K (2020) Upregulating microRNA-874-3p inhibits CXCL12 expression to promote angiogenesis and suppress inflammatory response in ischemic stroke. Am J Physiol Cell Physiol 319(3):C579–C588
Bruderer M, Alini M, Stoddart MJ (2013) Role of HOXA9 and VEZF1 in endothelial biology. J Vasc Res 50(4):265–278
Sugiyama A, Hirashima M (2022) Fetal nuchal edema and developmental anomalies caused by gene mutations in mice. Front Cell Dev Biol 10:949013
Du K, Zhao C, Wang L, Wang Y, Zhang K-Z, Shen X-Y et al (2019) MiR-191 inhibit angiogenesis after acute ischemic stroke targeting VEZF1. Aging (Albany NY) 11(9):2762
Zhao P, Xu S, Huang Z, Deng P, Zhang Y (2021) Identify specific gene pairs for subarachnoid hemorrhage based on wavelet analysis and genetic algorithm. PLoS ONE 16(6):e0253219
AlAbdi L, He M, Yang Q, Norvil AB, Gowher H (2018) The transcription factor Vezf1 represses the expression of the antiangiogenic factor Cited2 in endothelial cells. J Biol Chem 293(28):11109–11118
Zou Z, Ocaya PA, Sun H, Kuhnert F, Stuhlmann H (2010) Targeted Vezf1-null mutation impairs vascular structure formation during embryonic stem cell differentiation. Arterioscler Thromb Vasc Biol 30(7):1378–1388
Zhang T, Xu D, Trefts E, Lv M, Inuzuka H, Song G et al (2023) Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. Science 380(6652):1372–1380
Lin SC, Hardie DG (2018) AMPK: sensing glucose as well as cellular energy status. Cell Metab 27(2):299–313
Green DR, Galluzzi L, Kroemer G (2014) Cell biology. Metab Control Cell Death Sci 345(6203):1250256
Yuan Y, Zhang Z, Wang Z, Liu J (2019) MiRNA-27b Regulates angiogenesis by targeting AMPK in mouse ischemic stroke model. Neuroscience 398:12–22
Yuan J, Amin P, Ofengeim D (2019) Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci 20(1):19–33
Green DR (2019) The coming decade of cell death research: five riddles. Cell 177(5):1094–1107
Wang H, Sun L, Su L, Rizo J, Liu L, Wang LF et al (2014) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 54(1):133–146
Henry CM, Martin SJ (2017) Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory “FADDosome” complex upon TRAIL stimulation. Mol Cell 65(4):715–29.e5
Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277(5327):815–818
Linkermann A, Bräsen JH, Darding M, Jin MK, Sanz AB, Heller JO et al (2013) Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A 110(29):12024–12029
Feng N, Wang Z, Wu Y, Zheng H, Jiang X, Wang Z et al (2022) ADAMTS9-AS2 promotes angiogenesis of brain microvascular endothelial cells through regulating miR-185-5p/IGFBP-2 axis in ischemic stroke. Mol Neurobiol 59(4):2593–2604
Sun Y, Ding S, Fan Y, Shen F, Dong Q, Zhao B et al (2021) MiR-429 inhibits the angiogenesis of human brain microvascular endothelial cells through SNAI2-mediated GSK-3β/β-catenin pathway. Comput Math Methods Med 2021:6753926
Sun P, Ma F, Xu Y, Zhou C, Stetler RA, Yin K-J (2021) Genetic deletion of endothelial microRNA-15a/16-1 promotes cerebral angiogenesis and neurological recovery in ischemic stroke through Src signaling pathway. J Cereb Blood Flow Metab 41(10):2725–2742
Liang C, Ni GX, Shi XL, Jia L, Wang YL (2020) Astragaloside IV regulates the HIF/VEGF/Notch signaling pathway through miRNA-210 to promote angiogenesis after ischemic stroke. Restor Neurol Neurosci 38(3):271–282
Li J, Lv H, Che Y (2020) microRNA-381-3p confers protection against ischemic stroke through promoting angiogenesis and inhibiting inflammation by suppressing Cebpb and Map3k8. Cell Mol Neurobiol 40(8):1307–1319
Sun P, Zhang K, Hassan SH, Zhang X, Tang X, Pu H et al (2020) Endothelium-targeted deletion of microRNA-15a/16-1 promotes poststroke angiogenesis and improves long-term neurological recovery. Circ Res 126(8):1040–1057
Fan J, Xu W, Nan S, Chang M, Zhang Y (2020) MicroRNA-384-5p promotes endothelial progenitor cell proliferation and angiogenesis in cerebral ischemic stroke through the delta-likeligand 4-mediated notch signaling pathway. Cerebrovasc Dis 49(1):39–54
Peng H, Yang H, Xiang X, Li S (2020) ΜicroRNA-221 participates in cerebral ischemic stroke by modulating endothelial cell function by regulating the PTEN/PI3K/AKT pathway. Exp Ther Med 19(1):443–450
Liang Z, Chi YJ, Lin GQ, Luo SH, Jiang QY, Chen YK (2018) MiRNA-26a promotes angiogenesis in a rat model of cerebral infarction via PI3K/AKT and MAPK/ERK pathway. Eur Rev Med Pharmacol Sci 22(11):3485–3492
Pan Q, Zheng J, Du D, Liao X, Ma C, Yang Y et al (2018) MicroRNA-126 priming enhances functions of endothelial progenitor cells under physiological and hypoxic conditions and their therapeutic efficacy in cerebral ischemic damage. Stem Cells Int 2018:2912347
Shi F-P, Wang X-H, Zhang H-X, Shang M-M, Liu X-X, Sun H-M et al (2018) MiR-103 regulates the angiogenesis of ischemic stroke rats by targeting vascular endothelial growth factor (VEGF). Iran J Basic Med Sci 21(3):318–324
Shan C, Ma Y (2018) MicroRNA-126/stromal cell-derived factor 1/C-X-C chemokine receptor type 7 signaling pathway promotes post-stroke angiogenesis of endothelial progenitor cell transplantation. Mol Med Rep 17(4):5300–5305
Su ZF, Sun ZW, Zhang Y, Wang S, Yu QG, Wu ZB (2017) Regulatory effects of miR-146a/b on the function of endothelial progenitor cells in acute ischemic stroke in mice. Kaohsiung J Med Sci 33(8):369–378
Fan Y, Ding S, Sun Y, Zhao B, Pan Y, Wan J (2018) MiR-377 regulates inflammation and angiogenesis in rats after cerebral ischemic injury. J Cell Biochem 119(1):327–337
Zeng L-L, He X-S, Liu J-R, Zheng C-B, Wang Y-T, Yang G-Y (2016) Lentivirus-mediated overexpression of microRNA-210 improves long-term outcomes after focal cerebral ischemia in mice. CNS Neurosci Ther 22(12):961–969
Sun J, Tao S, Liu L, Guo D, Xia Z, Huang M (2016) miR-140-5p regulates angiogenesis following ischemic stroke by targeting VEGFA. Mol Med Rep 13(5):4499–4505
Li Q, He Q, Baral S, Mao L, Li Y, Jin H et al (2016) MicroRNA-493 regulates angiogenesis in a rat model of ischemic stroke by targeting MIF. Febs J 283(9):1720–1733
Caballero-Garrido E, Pena-Philippides JC, Lordkipanidze T, Bragin D, Yang Y, Erhardt EB et al (2015) In vivo inhibition of miR-155 promotes recovery after experimental mouse stroke. J Neurosci 35(36):12446–12464
Li Y, Mao L, Gao Y, Baral S, Zhou Y, Hu B (2015) MicroRNA-107 contributes to post-stroke angiogenesis by targeting Dicer-1. Sci Rep 5:13316
Feng N, Wang Z, Zhang Z, He X, Wang C, Zhang L (2015) miR-487b promotes human umbilical vein endothelial cell proliferation, migration, invasion and tube formation through regulating THBS1. Neurosci Lett 591:1–7
Lou YL, Guo F, Liu F, Gao FL, Zhang PQ, Niu X et al (2012) miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol Cell Biochem 370(1–2):45–51
Ahmadi R, Heidarian E, Fadaei R, Moradi N, Malek M, Fallah S (2018) miR-342–5p expression levels in coronary artery disease patients and its association with inflammatory cytokines. Clin Lab 64(4):84
Wei Y, Nazari-Jahantigh M, Chan L, Zhu M, Heyll K, Corbalán-Campos J et al (2013) The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1-and microRNA-155–dependent pathway during atherosclerosis. Circulation 127(15):1609–1619
Qu Y, Liu D, Jia H, Yang Z (2019) Circular RNA rno_circ_0004002 regulates cell proliferation, apoptosis, and epithelial-mesenchymal transition through targeting miR-342-5p and Wnt3a in anorectal malformations. J Cell Biochem 120(9):15483–15493
Luis TC, Weerkamp F, Naber BA, Baert MR, de Haas EF, Nikolic T et al (2009) Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. Blood J Am Soc Hematol 113(3):546–554
Sun X, Zhang R, Lin X, Xu X (2008) Wnt3a regulates the development of cardiac neural crest cells by modulating expression of cysteine-rich intestinal protein 2 in rhombomere 6. Circ Res 102(7):831–839
Ramsey SA, Vengrenyuk Y, Menon P, Podolsky I, Feig JE, Aderem A et al (2014) Epigenome-guided analysis of the transcriptome of plaque macrophages during atherosclerosis regression reveals activation of the Wnt signaling pathway. PLoS Genet 10(12):e1004828
Wu X, Wang J, Jiang H, Hu Q, Chen J, Zhang J et al (2014) Wnt3a activates β1-integrin and regulates migration and adhesion of vascular smooth muscle cells. Mol Med Rep 9(4):1159–1164
Sun H, Feng J, Ma Y, Cai D, Luo Y, Wang Q et al (2021) Down-regulation of microRNA-342-5p or up-regulation of Wnt3a Inhibits angiogenesis and maintains atherosclerotic plaque stability in atherosclerosis mice. Nanoscale Res Lett 16(1):165
Di M, Zhang Y, Zeng R, Liu X, Chen W, Zhang M et al (2021) The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs. Int J Biol Sci 17(15):4122–4139
Zhang Y, Liu Y, Zhang H, Wang M, Zhang J (2015) Mmu-miR-351 attenuates the survival of cardiac arterial endothelial cells through targeting STAT3 in the atherosclerotic mice. Biochem Biophys Res Commun 468(1–2):300–305
Liang T, Gao F, Jiang J, Lu YW, Zhang F, Wang Y et al (2020) Loss of phosphatase and tensin homolog promotes cardiomyocyte proliferation and cardiac repair after myocardial infarction. Circulation 142(22):2196–2199
Wang K, Liu J, Li Y-L, Li J-P, Zhang R (2022) Ubiquitination/de-ubiquitination: a promising therapeutic target for PTEN reactivation in cancer. Biochim Biophys Acta (BBA) 1877(3):188723
Shao C, Li Z, Ahmad N, Liu X (2017) Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb. Cell Cycle 16(10):957–967
Huang S, Li X, Zheng H, Si X, Li B, Wei G et al (2019) Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation 139(25):2857–2876
Bersell K, Arab S, Haring B, Kühn B (2009) Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138(2):257–270
Vasjari L, Bresan S, Biskup C, Pai G, Rubio I (2019) Ras signals principally via Erk in G1 but cooperates with PI3K/Akt for Cyclin D induction and S-phase entry. Cell Cycle 18(2):204–225
Skotheim JM, Di Talia S, Siggia ED, Cross FR (2008) Positive feedback of G1 cyclins ensures coherent cell cycle entry. Nature 454(7202):291–296
Santos SD, Wollman R, Meyer T, Ferrell JE Jr (2012) Spatial positive feedback at the onset of mitosis. Cell 149(7):1500–1513
Araujo AR, Gelens L, Sheriff RS, Santos SD (2016) Positive feedback keeps duration of mitosis temporally insulated from upstream cell-cycle events. Mol Cell 64(2):362–375
Li M, Zheng H, Han Y, Chen Y, Li B, Chen G et al (2021) LncRNA Snhg1-driven self-reinforcing regulatory network promoted cardiac regeneration and repair after myocardial infarction. Theranostics 11(19):9397–9414
Lee S, Kopp F, Chang TC, Sataluri A, Chen B, Sivakumar S et al (2016) Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO proteins. Cell 164(1–2):69–80
Yang Z, Zhao Y, Lin G, Zhou X, Jiang X, Zhao H (2019) Noncoding RNA activated by DNA damage (NORAD): biologic function and mechanisms in human cancers. Clin Chim Acta 489:5–9
Soghli N, Yousefi T, Abolghasemi M, Qujeq D (2021) NORAD, a critical long non-coding RNA in human cancers. Life Sci 264:118665
Miao Z, Guo X, Tian L (2019) The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608. Gene 687:116–124
Shi P, Zhang J, Li X, Li W, Li H, Fu P (2021) Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis. Cell Cycle 20(13):1295–1307
Kawasaki N, Miwa T, Hokari S, Sakurai T, Ohmori K, Miyauchi K et al (2018) Long noncoding RNA NORAD regulates transforming growth factor-β signaling and epithelial-to-mesenchymal transition-like phenotype. Cancer Sci 109(7):2211–2220
Ekhteraei-Tousi S, Mohammad-Soltani B, Sadeghizadeh M, Mowla SJ, Parsi S, Soleimani M (2015) Inhibitory effect of hsa-miR-590-5p on cardiosphere-derived stem cells differentiation through downregulation of TGFB signaling. J Cell Biochem 116(1):179–191
Jafarzadeh M, Soltani BM (2016) Hsa-miR-590-5p interaction with SMAD3 transcript supports its regulatory effect on the TGFβ signaling pathway. Cell J 18(1):7–12
Nallamshetty S, Chan SY, Loscalzo J (2013) Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med 64:20–30
Zhao X, Wei X, Wang X, Qi G (2020) Long non-coding RNA NORAD regulates angiogenesis of human umbilical vein endothelial cells via miR-590-3p under hypoxic conditions. Mol Med Rep 21(6):2560–2570
Peng B, Wu D, Sun J, Huang S, Wu F, Gu X et al (2016) The correlation between mirnas levels and collateral pathway in patients with Acute Cerebral Infraction. Apoplexy Nervous Dis 33(2):79–80
Fang Y, Davies PF (2012) Site-specific microRNA-92a regulation of Krüppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 32(4):979–987
Sangwung P, Zhou G, Nayak L, Chan ER, Kumar S, Kang D-W et al (2017) KLF2 and KLF4 control endothelial identity and vascular integrity. JCI Insight 2(4):65
Zhang X, Wang L, Han Z, Dong J, Pang D, Fu Y et al (2020) KLF4 alleviates cerebral vascular injury by ameliorating vascular endothelial inflammation and regulating tight junction protein expression following ischemic stroke. J Neuroinflammation 17(1):1–16
Yang H, Xi X, Zhao B, Su Z, Wang Z (2018) KLF4 protects brain microvascular endothelial cells from ischemic stroke induced apoptosis by transcriptionally activating MALAT1. Biochem Biophys Res Commun 495(3):2376–2382
Wang C, Dong J, Sun J, Huang S, Wu F, Zhang X et al (2021) Silencing of lncRNA XIST impairs angiogenesis and exacerbates cerebral vascular injury after ischemic stroke. Mol Ther Nucleic Acids 26:148–160
Nurnberg ST, Guerraty MA, Wirka RC, Rao HS, Pjanic M, Norton S et al (2020) Genomic profiling of human vascular cells identifies TWIST1 as a causal gene for common vascular diseases. PLoS Genet 16(1):e1008538
Mammoto A, Hendee K, Muyleart M, Mammoto T (2020) Endothelial Twist1-PDGFB signaling mediates hypoxia-induced proliferation and migration of αSMA-positive cells. Sci Rep 10(1):1–12
Mahmoud MM, Kim HR, Xing R, Hsiao S, Mammoto A, Chen J et al (2016) TWIST1 integrates endothelial responses to flow in vascular dysfunction and atherosclerosis. Circ Res 119(3):450–462
Li J, Liu C-H, Sun Y, Gong Y, Fu Z, Evans LP et al (2014) Endothelial TWIST1 promotes pathological ocular angiogenesis. Invest Ophthalmol Vis Sci 55(12):8267–8277
Mammoto T, Jiang A, Jiang E, Mammoto A (2016) Role of Twist1 phosphorylation in angiogenesis and pulmonary fibrosis. Am J Respir Cell Mol Biol 55(5):633–644
Mammoto T, Jiang E, Jiang A, Lu Y, Juan AM, Chen J et al (2013) Twist1 controls lung vascular permeability and endotoxin-induced pulmonary edema by altering Tie2 expression. PLoS ONE 8(9):e73407
Kaushik K, Das A (2020) TWIST1-Reprogrammed endothelial cell transplantation potentiates neovascularization-mediated diabetic wound tissue regeneration. Diabetes 69(6):1232–1247
Chen H-F, Huang C-H, Liu C-J, Hung J-J, Hsu C-C, Teng S-C et al (2014) Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis. Nat Commun 5(1):1–13
Hendee K, Hunyenyiwa T, Matus K, Toledo M, Mammoto A, Mammoto T (2021) Twist1 signaling in age-dependent decline in angiogenesis and lung regeneration. Aging (Albany NY) 13(6):7781
Mammoto T, Muyleart M, Konduri GG, Mammoto A (2018) Twist1 in hypoxia-induced pulmonary hypertension through transforming growth factor-β–Smad signaling. Am J Respir Cell Mol Biol 58(2):194–207
Yang M-H, Wu K-J (2008) TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 7(14):2090–2096
Guo Y, Zi X, Koontz Z, Kim A, Xie J, Gorlick R et al (2007) Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells. J Orthop Res 25(7):964–971
Wirrig EE, Yutzey KE (2014) Conserved transcriptional regulatory mechanisms in aortic valve development and disease. Arterioscler Thromb Vasc Biol 34(4):737–741
Cheng GZ, Zhang W, Wang L-H (2008) Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Can Res 68(4):957–960
Xue G, Restuccia DF, Lan Q, Hynx D, Dirnhofer S, Hess D et al (2012) Akt/PKB-mediated phosphorylation of twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axestwist1 phosphorylation promotes cancer cell invasion. Cancer Discov 2(3):248–259
Yan G, Zhao H, Hong X (2020) LncRNA MACC1-AS1 attenuates microvascular endothelial cell injury and promotes angiogenesis under hypoxic conditions via modulating miR-6867-5p/TWIST1 in human brain microvascular endothelial cells. Ann Transl Med 8(14):876
Liu H, Li J, Koirala P, Ding X, Chen B, Wang Y et al (2016) Long non-coding RNAs as prognostic markers in human breast cancer. Oncotarget 7(15):20584
Michalik KM, You X, Manavski Y, Doddaballapur A, Zörnig M, Braun T et al (2014) Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 114(9):1389–1397
Hutter R, Speidl WS, Valdiviezo C, Sauter B, Corti R, Fuster V et al (2013) Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis. J Cardiovasc Transl Res 6(4):558–569
Perrotta I, Moraca FM, Sciangula A, Aquila S, Mazzulla S (2015) HIF-1α and VEGF: immunohistochemical profile and possible function in human aortic valve stenosis. Ultrastruct Pathol 39(3):198–206
Deng W, Feng X, Li X, Wang D, Sun L (2016) Hypoxia-inducible factor 1 in autoimmune diseases. Cell Immunol 303:7–15
Bao MH, Li GY, Huang XS, Tang L, Dong LP, Li JM (2018) Long Noncoding RNA LINC00657 acting as a miR-590-3p sponge to facilitate low concentration oxidized low-density lipoprotein-induced angiogenesis. Mol Pharmacol 93(4):368–375
Chen ZL, Chen YX, Zhou J, Li Y, Gong CY, Wang XB (2020) LncRNA HULC alleviates HUVEC inflammation and improves angiogenesis after myocardial infarction through down-regulating miR-29b. Eur Rev Med Pharmacol Sci 24(11):6288–6298
Li X, Sun Y, Huang S, Chen Y, Chen X, Li M et al (2019) Inhibition of AZIN2-sv induces neovascularization and improves prognosis after myocardial infarction by blocking ubiquitin-dependent talin1 degradation and activating the Akt pathway. EBioMedicine 39:69–82
Gao Q, Wang Y (2021) LncRNA FTX regulates angiogenesis through miR-342-3p/SPI1 axis in stroke. Neuropsychiatr Dis Treat 17:3617–3625
Huang Y, Wang Y, Liu X, Ouyang Y (2021) Silencing lncRNA HOTAIR improves the recovery of neurological function in ischemic stroke via the miR-148a-3p/KLF6 axis. Brain Res Bull 176:43–53
Sui S, Sun L, Zhang W, Li J, Han J, Zheng J et al (2021) LncRNA MEG8 attenuates cerebral ischemia after ischemic stroke through targeting miR-130a-5p/VEGFA signaling. Cell Mol Neurobiol 41(6):1311–1324
Gao C, Zhang CC, Yang HX, Hao YN (2020) MALAT1 protected the angiogenesis function of human brain microvascular endothelial cells (HBMECs) under oxygen glucose deprivation/re-oxygenation (OGD/R) challenge by interacting with miR-205-5p/VEGFA pathway. Neuroscience 435:135–145
Zhang M, Tang M, Wu Q, Wang Z, Chen Z, Ding H et al (2020) LncRNA DANCR attenuates brain microvascular endothelial cell damage induced by oxygen-glucose deprivation through regulating of miR-33a-5p/XBP1s. Aging (Albany NY) 12(2):1778–1791
Hu C, Bai X, Liu C, Hu Z (2019) Long noncoding RNA XIST participates hypoxia-induced angiogenesis in human brain microvascular endothelial cells through regulating miR-485/SOX7 axis. Am J Transl Res 11(10):6487–6497
Long FQ, Su QJ, Zhou JX, Wang DS, Li PX, Zeng CS et al (2018) LncRNA SNHG12 ameliorates brain microvascular endothelial cell injury by targeting miR-199a. Neural Regen Res 13(11):1919–1926
Zhao M, Wang J, Xi X, Tan N, Zhang L (2018) SNHG12 promotes angiogenesis following ischemic stroke via regulating miR-150/VEGF Pathway. Neuroscience 390:231–240
Wang Z, Wang R, Wang K, Liu X (2018) Upregulated long noncoding RNA Snhg1 promotes the angiogenesis of brain microvascular endothelial cells after oxygen-glucose deprivation treatment by targeting miR-199a. Can J Physiol Pharmacol 96(9):909–915
Li L, Wang M, Mei Z, Cao W, Yang Y, Wang Y et al (2017) lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia. Biomed Pharmacother 96:165–172
Cheng X, Liu Z, Zhang H, Lian Y (2021) Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590–5p mediated KLF6/VEGF signaling pathway. Cell Cycle 8:1–18
Tzavlaki K, Moustakas A (2020) TGF-β Signaling. Biomolecules 10(3):487
Benn A, Hiepen C, Osterland M, Schütte C, Zwijsen A, Knaus P (2017) Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence. FASEB J 31(11):4720–4733
Seystahl K, Tritschler I, Szabo E, Tabatabai G, Weller M (2015) Differential regulation of TGF-β–induced, ALK-5–mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma. Neuro Oncol 17(2):254–265
Zhu Q, Kim YH, Wang D, Oh SP, Luo K (2013) SnoN facilitates ALK1–Smad1/5 signaling during embryonic angiogenesis. J Cell Biol 202(6):937–950
Benn A, Alonso F, Mangelschots J, Génot E, Lox M, Zwijsen A (2020) BMP-SMAD1/5 signaling regulates retinal vascular development. Biomolecules 10(3):488
Long X, Qiu Z, Li C, Wang Y, Li J, Zhao R et al (2022) CircERBB2IP promotes post-infarction revascularization via the miR-145a-5p/Smad5 axis. Mol Ther Nucleic Acids 28:573–586
Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW et al (2015) A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev 29(12):1271–1284
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J et al (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21(21):2747–2761
Park GS, Oh H, Kim M, Kim T, Johnson RL, Irvine KD et al (2016) An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2. Oncotarget 7(17):24063–24075
Zhao B, Lei QY, Guan KL (2008) The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20(6):638–646
Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T et al (2011) LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res 71(3):873–883
Li J, Chen X, Ding X, Cheng Y, Zhao B, Lai ZC et al (2013) LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. Cell Rep 5(6):1650–1663
Yao F, Liu H, Li Z, Zhong C, Fang W (2015) Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells. Tumour Biol 36(3):2049–2057
Ji T, Liu D, Shao W, Yang W, Wu H, Bian X (2012) Decreased expression of LATS1 is correlated with the progression and prognosis of glioma. J Exp Clin Cancer Res 31(1):67
Zhang H, Sun J, Ju W, Li B, Lou Y, Zhang G et al (2019) Apatinib suppresses breast cancer cells proliferation and invasion via angiomotin inhibition. Am J Transl Res 11(7):4460–4469
Moroishi T, Hayashi T, Pan WW, Fujita Y, Holt MV, Qin J et al (2016) The Hippo pathway kinases LATS1/2 suppress cancer immunity. Cell 167(6):1525–39.e17
Gao WQ, Hu XM, Zhang Q, Yang L, Lv XZ, Chen S et al (2020) Downregulation of circFASTKD1 ameliorates myocardial infarction by promoting angiogenesis. Aging (Albany NY) 13(3):3588–3604
Fu J, Bai P, Chen Y, Yu T, Li F (2019) Inhibition of miR-495 improves both vascular remodeling and angiogenesis in pulmonary hypertension. J Vasc Res 56(2):97–106
Gerald D, Adini I, Shechter S, Perruzzi C, Varnau J, Hopkins B et al (2013) RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription. Nat Commun 4:2824
Jin F, Xing J (2017) Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity. Neurol Sci 38(11):2015–2023
Jin F, Xing J (2018) Circulating miR-126 and miR-130a levels correlate with lower disease risk, disease severity, and reduced inflammatory cytokine levels in acute ischemic stroke patients. Neurol Sci 39(10):1757–1765
Li J, Wang J, Wang Z (2021) Circ_0006768 upregulation attenuates oxygen-glucose deprivation/reoxygenation-induced human brain microvascular endothelial cell injuries by upregulating VEZF1 via miR-222-3p inhibition. Metab Brain Dis 36(8):2521–2534
Cao X, He W, Pang Y, Cao Y, Qin A (2020) Redox-dependent and independent effects of thioredoxin interacting protein. Biol Chem 401(11):1215–1231
Chistiakov DA, Orekhov AN, Bobryshev YV (2017) Effects of shear stress on endothelial cells: go with the flow. Acta Physiol 219(2):382–408
Mohamed IN, Ishrat T, Fagan SC, El-Remessy AB (2015) Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit. Antioxid Redox Signal 22(13):1188–1206
Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11(2):136–140
Masola V, Carraro A, Granata S, Signorini L, Bellin G, Violi P et al (2019) In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. J Transl Med 17(1):12
Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266(1):37–52
Xiao X, Chen M, Xu Y, Huang S, Liang J, Cao Y et al (2020) Sodium butyrate inhibits neovascularization partially via TNXIP/VEGFR2 pathway. Oxid Med Cell Longev 2020:6415671
Li J, Yue Z, Xiong W, Sun P, You K, Wang J (2017) TXNIP overexpression suppresses proliferation and induces apoptosis in SMMC7221 cells through ROS generation and MAPK pathway activation. Oncol Rep 37(6):3369–3376
Byon CH, Han T, Wu J, Hui ST (2015) Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice. Atherosclerosis 241(2):313–321
Wang J, Wang X-J, Zhang Y, Shi W-J, Lei Z-D, Jiao X-Y (2022) TXNIP knockout improves cardiac function after myocardial infarction by promoting angiogenesis and reducing cardiomyocyte apoptosis. Cardiovasc Diagnosis Therapy 12(3):289
Lei X, Yang Y (2022) Oxidized low-density lipoprotein contributes to injury of endothelial cells via the circ_0090231/miR-9-5p/TXNIP axis. Cent Eur J Immunol 47(1):41–57
Su X, Wang J, Chen W, Li Z, Fu X, Yang A (2016) Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway. Oncotarget 7(9):9939
Huang X, Li Y, Li X, Fan D, Xin HB, Fu M (2020) TRIM14 promotes endothelial activation via activating NF-κB signaling pathway. J Mol Cell Biol 12(3):176–189
Zhang C, Wang L, Shen Y (2021) Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/TRIM14 axis in atherosclerosis. BMC Cardiovasc Disord 21(1):207
Liang H, Liao M, Zhao W, Zheng X, Xu F, Wang H et al (2018) CXCL16/ROCK1 signaling pathway exacerbates acute kidney injury induced by ischemia-reperfusion. Biomed Pharmacother 98:347–356
Qiao CY, Qiao TY, Jin H, Liu LL, Zheng MD, Wang ZL (2020) LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis. Eur Rev Med Pharmacol Sci 24(1):200–212
Wang T, Ren Y, Liu R, Ma J, Shi Y, Zhang L et al (2017) miR-195-5p suppresses the proliferation, migration, and invasion of oral squamous cell carcinoma by targeting TRIM14. Biomed Res Int 2017:7378148
Deng Y, Zhu H, Xiao L, Liu C, Meng X (2020) Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis. Aging (Albany NY) 13(2):2198–2211
Nenasheva VV, Kovaleva GV, Khaidarova NV, Novosadova EV, Manuilova ES, Antonov SA et al (2014) Trim14 overexpression causes the same transcriptional changes in mouse embryonic stem cells and human HEK293 cells. In Vitro Cell Dev Biol Anim 50(2):121–128
Si X, Zheng H, Wei G, Li M, Li W, Wang H et al (2020) circRNA Hipk3 induces cardiac regeneration after myocardial infarction in mice by binding to Notch1 and miR-133a. Mol Therapy Nucleic Acsids 21:636–655
Zhang M, Wang Z, Cheng Q, Wang Z, Lv X, Wang Z et al (2020) Circular RNA (circRNA) CDYL Induces myocardial regeneration by ceRNA after myocardial infarction. Med Sci Monit 26:e923188
Liu J, Zhang H, Di K, Hou L, Yu S (2022) Circular noncoding RNA circ_0007865, serves as a competing endogenous RNA, targeting the miR-214-3p/FKBP5 axis to regulate oxygen-glucose deprivation-induced injury in brain microvascular endothelial cells. NeuroReport 33(4):163–172
Bai X, Liu X, Wu H, Feng J, Chen H, Zhou D (2022) CircFUNDC1 knockdown alleviates oxygen-glucose deprivation-induced human brain microvascular endothelial cell injuries by inhibiting PTEN via miR-375. Neurosci Lett 770:136381
Yang J (2022) Mmu_circ_0000271 regulated the growth of ox-LDL-stimulated mouse vascular smooth muscle cells via sponging miR-5123. Genes Genomics 44(9):1099–1108
Wang P, Zhang H, Wang Y (2022) Circ_0003423 alleviates oxidized low-density lipoprotein-induced endothelial cell injury by sponging miR-142-3p and activating sirtuin 3/superoxide dismutase 2 pathway. J Surg Res 277:384–397
Li X, Kang X, Di Y, Sun S, Yang L, Wang B et al (2022) CircCHMP5 contributes to Ox-LDL-induced endothelial cell injury through the regulation of MiR-532–5p/ROCK2 axis. Cardiovasc Drugs Ther 4(9):1099–1108
Zhang D, Zhang G, Yu K, Zhang X, Jiang A (2022) Circ_0003204 knockdown protects endothelial cells against oxidized low-density lipoprotein-induced injuries by targeting the miR-491-5p-ICAM1 pathway. J Thromb Thrombolysis 53(2):302–312
Chang W, Wang J (2019) Exosomes and their noncoding RNA cargo are emerging as new modulators for diabetes mellitus. Cells 8(8):853
Yoon YJ, Kim OY, Gho YS (2014) Extracellular vesicles as emerging intercellular communicasomes. BMB Rep 47(10):531–539
Mathieu M, Martin-Jaular L, Lavieu G, Théry C (2019) Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol 21(1):9–17
Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200(4):373–383
van Niel G, D’Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213–228
Jafari A, Babajani A, Abdollahpour-Alitappeh M, Ahmadi N, Rezaei-Tavirani M (2021) Exosomes and cancer: from molecular mechanisms to clinical applications. Med Oncol 38(4):45
Lee JH, Song J, Kim IG, You G, Kim H, Ahn JH et al (2022) Exosome-mediated delivery of transforming growth factor-β receptor 1 kinase inhibitors and toll-like receptor 7/8 agonists for combination therapy of tumors. Acta Biomater 141:354–363
Xiong F, Mao R, Zhao R, Zhang L, Tan K, Liu C et al (2022) Plasma exosomal S1PR5 and CARNS1 as potential non-invasive screening biomarkers of coronary heart disease. Front Cardiovasc Med 9:845673
Brennan K, Martin K, FitzGerald SP, O’Sullivan J, Wu Y, Blanco A et al (2020) A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep 10(1):1039
Zaborowski MP, Balaj L, Breakefield XO, Lai CP (2015) Extracellular vesicles: composition, biological relevance, and methods of study. Bioscience 65(8):783–797
Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J et al (2020) Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther 5(1):145
Urbanelli L, Magini A, Buratta S, Brozzi A, Sagini K, Polchi A et al (2013) Signaling pathways in exosomes biogenesis, secretion and fate. Genes 4(2):152–170
Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):6977
Saad MG, Beyenal H, Dong WJ (2021) Exosomes as Powerful engines in cancer: isolation, characterization and detection techniques. Biosensors 11(12):518
Zhang Y, Liu Y, Liu H, Tang WH (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9:19
Record M, Carayon K, Poirot M, Silvente-Poirot S (2014) Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochem Biophys Acta 1841(1):108–120
Turchinovich A, Drapkina O, Tonevitsky A (2019) Transcriptome of extracellular vesicles: state-of-the-art. Front Immunol 10:202
Chen Y, Zhao Y, Yin Y, Jia X, Mao L (2021) Mechanism of cargo sorting into small extracellular vesicles. Bioengineered 12(1):8186–8201
Willms E, Johansson HJ, Mäger I, Lee Y, Blomberg KE, Sadik M et al (2016) Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep 6:22519
Barile L, Moccetti T, Marbán E, Vassalli G (2017) Roles of exosomes in cardioprotection. Eur Heart J 38(18):1372–1379
Fu L, Wu SS (2021) Advances in studies on exosomes and microvesicles as markers of cardiovascular disease. Eur Rev Med Pharmacol Sci 25(6):2622–2629
Guo D, Xu Y, Ding J, Dong J, Jia N, Li Y et al (2020) Roles and clinical applications of exosomes in cardiovascular disease. Biomed Res Int 2020:5424281
Sahoo S, Losordo DW (2014) Exosomes and cardiac repair after myocardial infarction. Circ Res 114(2):333–344
Su Q, Lv X-W, Xu Y-L, Cai R-P, Dai R-X, Yang X-H et al (2021) Exosomal LINC00174 derived from vascular endothelial cells attenuates myocardial I/R injury via p53-mediated autophagy and apoptosis. Mol Therapy-Nucleic Acids 23:1304–1322
Yuan Z, Huang W (2021) New developments in exosomal lncRNAs in cardiovascular diseases. Front Cardiovasc Med 8:709169
Peng M, Sun R, Hong Y, Wang J, Xie Y, Zhang X et al (2022) Extracellular vesicles carrying proinflammatory factors may spread atherosclerosis to remote locations. Cell Mol Life Sci 79(8):430
Henning RJ (2021) Cardiovascular exosomes and MicroRNAs in cardiovascular physiology and pathophysiology. J Cardiovasc Transl Res 14(2):195–212
Pironti G, Strachan RT, Abraham D, Mon-Wei YuS, Chen M, Chen W et al (2015) Circulating exosomes induced by cardiac pressure overload contain functional angiotensin ii type 1 receptors. Circulation 131(24):2120–2130
Sluijter JP, Verhage V, Deddens JC, van den Akker F, Doevendans PA (2014) Microvesicles and exosomes for intracardiac communication. Cardiovasc Res 102(2):302–311
Cambier L, Giani JF, Liu W, Ijichi T, Echavez AK, Valle J et al (2018) Angiotensin II-induced end-organ damage in mice is attenuated by human exosomes and by an exosomal Y RNA fragment. Hypertension 72(2):370–380
Davidson SM, Riquelme JA, Takov K, Vicencio JM, Boi-Doku C, Khoo V et al (2018) Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro. J Cell Mol Med 22(1):141–151
Malik ZA, Kott KS, Poe AJ, Kuo T, Chen L, Ferrara KW et al (2013) Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol 304(7):H954–H965
Xu MY, Ye ZS, Song XT, Huang RC (2019) Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review. Stem Cell Res Ther 10(1):194
Bai S, Yin Q, Dong T, Dai F, Qin Y, Ye L et al (2020) Endothelial progenitor cell-derived exosomes ameliorate endothelial dysfunction in a mouse model of diabetes. Biomed Pharmacother 131:110756
Wang Y, Zhao R, Liu W, Wang Z, Rong J, Long X, et al. (2019) Exosomal circHIPK3 released from hypoxia-pretreated cardiomyocytes regulates oxidative damage in cardiac microvascular endothelial cells via the miR-29a/IGF-1 pathway. Oxidative medicine and cellular longevity
Wang Y, Zhao R, Shen C, Liu W, Yuan J, Li C, et al. (2020) Exosomal CircHIPK3 released from hypoxia-induced cardiomyocytes regulates cardiac angiogenesis after myocardial infarction. Oxidative medicine and cellular longevity
Ni Y-Q, Lin X, Zhan J-K, Liu Y-S (2020) Roles and functions of exosomal non-coding RNAs in vascular aging. Aging Dis 11(1):164
Vizcaíno C, Mansilla S, Portugal J (2015) Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther 152:111–124
Schüttler D, Clauss S, Weckbach LT, Brunner S (2019) Molecular mechanisms of cardiac remodeling and regeneration in physical exercise. Cells 8(10):1128
Li R, Geng HH, Xiao J, Qin XT, Wang F, Xing JH et al (2016) miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1. Sci Rep 6:29082
Su F, Geng J, Li X, Qiao C, Luo L, Feng J et al (2017) SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab-resistant ovarian cancer model. Oncol Rep 38(5):2677–2684
Huang Y, Chen L, Feng Z, Chen W, Yan S, Yang R et al (2021) EPC-Derived exosomal miR-1246 and miR-1290 regulate phenotypic changes of fibroblasts to endothelial cells to exert protective effects on myocardial infarction by targeting ELF5 and SP1. Front Cell Dev Biol 9:647763
Chan HS, Chang SJ, Wang TY, Ko HJ, Lin YC, Lin KT et al (2012) Serine protease PRSS23 is upregulated by estrogen receptor α and associated with proliferation of breast cancer cells. PLoS ONE 7(1):e30397
Wang Z, Gao D, Wang S, Lin H, Wang Y, Xu W (2021) Exosomal microRNA-1246 from human umbilical cord mesenchymal stem cells potentiates myocardial angiogenesis in chronic heart failure. Cell Biol Int 45(11):2211–2225
Nie X, Su L, Zhou Y, Zhao Y, Shi D, Liu Y et al (2014) Association between plasma levels of microRNA-126 and coronary collaterals in patients with coronary artery disease. Zhonghua Xin Xue Guan Bing Za Zhi 42(7):561–565
Jakob P, Doerries C, Briand S, Mocharla P, Kränkel N, Besler C et al (2012) Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 126(25):2962–2975
Duan S, Wang C, Xu X, Zhang X, Su G, Li Y et al (2022) Peripheral serum exosomes isolated from patients with acute myocardial infarction promote endothelial cell angiogenesis via the miR-126-3p/TSC1/mTORC1/HIF-1α pathway. Int J Nanomed 17:1577–1592
Yang Y, Cai Y, Zhang Y, Liu J, Xu Z (2018) Exosomes secreted by adipose-derived stem cells contribute to angiogenesis of brain microvascular endothelial cells following oxygen-glucose deprivation in vitro through microRNA-181b/TRPM7 axis. J Mol Neurosci 65(1):74–83
Cao S, Xiao L, Rao JN, Zou T, Liu L, Zhang D et al (2014) Inhibition of Smurf2 translation by miR-322/503 modulates TGF-β/Smad2 signaling and intestinal epithelial homeostasis. Mol Biol Cell 25(8):1234–1243
Hassan MO, Duarte R, Dix-Peek T, Dickens C, Naidoo S, Vachiat A et al (2018) Transforming Growth Factor-β Protects against Inflammation-Related Atherosclerosis in South African CKD Patients. Int J Nephrol 2018:8702372
Huang SS, Liu IH, Chen CL, Chang JM, Johnson FE, Huang JS (2017) 7-Dehydrocholesterol (7-DHC), but not cholesterol, causes suppression of canonical TGF-β signaling and is likely involved in the development of atherosclerotic cardiovascular disease (ASCVD). J Cell Biochem 118(6):1387–1400
Wei L, Zhao S, Wang G, Zhang S, Luo W, Qin Z et al (2018) SMAD7 methylation as a novel marker in atherosclerosis. Biochem Biophys Res Commun 496(2):700–705
Gu W, Hong X, Le Bras A, Nowak WN, Issa Bhaloo S, Deng J et al (2018) Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts. J Biol Chem 293(21):8089–8102
Wang Y, Xu Z, Wang X, Zheng J, Peng L, Zhou Y et al (2021) Extracellular-vesicle containing miRNA-503-5p released by macrophages contributes to atherosclerosis. Aging (Albany NY) 13(8):12239–12257
Reiss AB, Ahmed S, Johnson M, Saeedullah U, De Leon J (2023) Exosomes in cardiovascular disease: from mechanism to therapeutic target. Metabolites 13(4):479
Ke X, Yang R, Wu F, Wang X, Liang J, Hu X et al (2021) Exosomal miR-218-5p/miR-363-3p from endothelial progenitor cells ameliorate myocardial infarction by targeting the p53/JMY signaling pathway. Oxid Med Cell Longev 2021:5529430
Yang M, Liu X, Jiang M, Li J, Tang Y, Zhou L (2021) miR-543 in human mesenchymal stem cell-derived exosomes promotes cardiac microvascular endothelial cell angiogenesis after myocardial infarction through COL4A1. IUBMB Life 73(7):927–940
Ning W, Li S, Yang W, Yang B, Xin C, Ping X et al (2021) Blocking exosomal miRNA-153-3p derived from bone marrow mesenchymal stem cells ameliorates hypoxia-induced myocardial and microvascular damage by targeting the ANGPT1-mediated VEGF/PI3k/Akt/eNOS pathway. Cell Signal 77:109812
Liu Y, Xu J, Gu R, Li Z, Wang K, Qi Y et al (2020) Circulating exosomal miR-144-3p inhibits the mobilization of endothelial progenitor cells post myocardial infarction via regulating the MMP9 pathway. Aging (Albany NY) 12(16):16294–16303
Wang Y, Zhao R, Shen C, Liu W, Yuan J, Li C et al (2020) Exosomal CircHIPK3 Released from Hypoxia-Induced Cardiomyocytes Regulates Cardiac Angiogenesis after Myocardial Infarction. Oxid Med Cell Longev 2020:8418407
Chen Y, Li S, Zhang Y, Wang M, Li X, Liu S et al (2021) The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics. Redox Biol 41:101910
Huang P, Wang L, Li Q, Tian X, Xu J, Xu J et al (2020) Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res 116(2):353–367
Sun L, Zhu W, Zhao P, Zhang J, Lu Y, Zhu Y et al (2020) Down-regulated exosomal MicroRNA-221 - 3p derived from senescent mesenchymal stem cells impairs heart repair. Front Cell Dev Biol 8:263
Geng T, Song Z-Y, Xing J-X, Wang B-X, Dai S-P, Xu Z-S (2020) Exosome derived from coronary serum of patients with myocardial infarction promotes angiogenesis through the miRNA-143/IGF-IR Pathway. Int J Nanomed 15:2647–2658
Liu S, Chen J, Shi J, Zhou W, Wang L, Fang W et al (2020) M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment. Basic Res Cardiol 115(2):22
Chen C-H, Hsu S-Y, Chiu C-C, Leu S (2019) MicroRNA-21 mediates the protective effect of cardiomyocyte-derived conditioned medium on ameliorating myocardial infarction in rats. Cells 8(8):935
Youn S-W, Li Y, Kim Y-M, Sudhahar V, Abdelsaid K, Kim HW et al (2019) Modification of cardiac progenitor cell-derived exosomes by miR-322 provides protection against myocardial infarction through Nox2-dependent angiogenesis. Antioxidants (Basel) 8(1):18
Ma T, Chen Y, Chen Y, Meng Q, Sun J, Shao L et al (2018) MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction. Stem Cells Int 2018:3290372
Namazi H, Mohit E, Namazi I, Rajabi S, Samadian A, Hajizadeh-Saffar E et al (2018) Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA. J Cell Biochem 119(5):4150–4160
Luo Q, Guo D, Liu G, Chen G, Hang M, Jin M (2017) Exosomes from MiR-126-overexpressing adscs are therapeutic in relieving acute myocardial ischaemic injury. Cell Physiol Biochem 44(6):2105–2116
Ribeiro-Rodrigues TM, Laundos TL, Pereira-Carvalho R, Batista-Almeida D, Pereira R, Coelho-Santos V et al (2017) Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis. Cardiovasc Res 113(11):1338–1350
Wang N, Chen C, Yang D, Liao Q, Luo H, Wang X et al (2017) Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis. Biochim Biophys Acta (BBA) 1863(8):2085–2092
Wang K, Jiang Z, Webster KA, Chen J, Hu H, Zhou Y et al (2017) Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal MicroRNA-21. Stem Cells Transl Med 6(1):209–222
Wang N, Chen C, Yang D, Liao Q, Luo H, Wang X et al (2017) Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis. Biochim Biophys Acta Mol Basis Dis 1863(8):2085–2092
Sánchez-Sánchez R, Gómez-Ferrer M, Reinal I, Buigues M, Villanueva-Bádenas E, Ontoria-Oviedo I et al (2021) miR-4732-3p in extracellular vesicles from mesenchymal stromal cells is cardioprotective during myocardial ischemia. Front Cell Dev Biol 9:734143
Li Q, Xu Y, Lv K, Wang Y, Zhong Z, Xiao C et al (2021) Small extracellular vesicles containing miR-486–5p promote angiogenesis after myocardial infarction in mice and nonhuman primates. Sci Transl Med 13(584):0202
Zhu D, Wang Y, Thomas M, McLaughlin K, Oguljahan B, Henderson J et al (2022) Exosomes from adipose-derived stem cells alleviate myocardial infarction via microRNA-31/FIH1/HIF-1α pathway. J Mol Cell Cardiol 162:10–19
Xuan W, Wang L, Xu M, Weintraub NL, Ashraf M (2019) miRNAs in extracellular vesicles from iPS-derived cardiac progenitor cells effectively reduce fibrosis and promote angiogenesis in infarcted heart. Stem Cells Int 2019:3726392
Yang M, Liao M, Liu R, Zhang Q, Zhang S, He Y et al (2022) Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with miR-223 ameliorate myocardial infarction through P53/S100A9 axis. Genomics 114(3):110319
Ottaviani L, Juni RP, de Abreu RC, Sansonetti M, Sampaio-Pinto V, Halkein J et al (2022) Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells. Mol Ther 30(6):2257–2273
Qiao L, Hu S, Liu S, Zhang H, Ma H, Huang K et al (2019) microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. J Clin Investig 129(6):2237–2250
Xu C, Yu H, Chen B, Ma Y, Lv P (2022) Serum exosomal mir-340-5p promotes angiogenesis in brain microvascular endothelial cells during oxygen-glucose deprivation. Neurochem Res 47(4):907–920
Acknowledgements
Not applicable.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
JZ involved to manuscript drafting and data collection.
Corresponding author
Ethics declarations
Competing interest
The authors declare no conflict of interest.
Consent for publication
Not applicable.
Ethical approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, J. Non-coding RNAs and angiogenesis in cardiovascular diseases: a comprehensive review. Mol Cell Biochem (2024). https://doi.org/10.1007/s11010-023-04919-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11010-023-04919-5